The present data clearly show that CRP and the other investigated pro-inflammatory biomarkers gradually increase from mild to moderate and/or severe COVID-19 cases and this is supported by an expansion of neutrophils and eosinophils together with a reduction in the lymphocyte count. The gene discussed is CRP; the disease is COVID-19.